CTTNBP2NL (CTTNBP2 N-terminal-like protein) was also upregulated; this is known to be associated with STRIPAK complexes, which have been broadly linked to metabolism, immune regulation, and cancer tumorigenesis (37). Here, CTTNBP2NL is linked to cancer.